Dashyant Dhanak

EVP & Chief Scientific Officer, Incyte.

Companies

Deciphera Pharmaceuticals, Inc.EVP & Chief Scientific Officer Sep 5, 2023 to Jun 11, 2024¹
IncyteEVP & Chief Scientific Officer Dec 12, 2018 to Jul 18, 2023²

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Jun 11, 2024Returned to company 184,088 shares of Deciphera Pharmaceuticals, Inc.⁴
Jun 11, 2024Granted 25,913 shares of Deciphera Pharmaceuticals, Inc.⁴
Feb 15, 2024Granted 17,275 shares of Deciphera Pharmaceuticals, Inc.⁵
Sep 15, 2023Granted 75,000 shares of Deciphera Pharmaceuticals, Inc.⁶
Sep 15, 2023Granted 65,900 shares of Deciphera Pharmaceuticals, Inc.⁶
Jul 14, 2023Granted 8,056 shares of Incyte³
Jul 3, 2023Shares withheld for tax 6,044 shares at $62.08 of Incyte⁷
Feb 16, 2023Exercised options 3,693 shares at $65.42 of Incyte⁸
Jan 26, 2023Sold 2,419 shares at $85.00 of Incyte⁹
Jan 20, 2023Granted 4,980 shares of Incyte¹⁰
Dec 12, 2022Shares withheld for tax 533 shares at $82.36 of Incyte¹¹
Jul 5, 2022Shares withheld for tax 2,181 shares at $79.25 of Incyte¹²
Jul 2, 2022Granted 11,274 shares of Incyte¹²
Jan 1, 2022Granted 8,678 shares of Incyte¹³
Dec 10, 2021Shares withheld for tax 533 shares at $65.40 of Incyte¹⁴
Nov 19, 2021Granted 2,355 shares of Incyte¹⁵
Nov 19, 2021Granted 379 shares of Incyte¹⁵
Oct 1, 2021Sold 389 shares at $68.67 of Incyte¹⁶

The numbers on this page point here. Each one links to the record it came from.